David A. Boyd - Publications

Carbapenemase-producing hypervirulent Klebsiella pneumoniae in Alberta, Canada, 2016-2024.

Journal: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

Published: September 23, 2025

Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8.

Journal: Microbial drug resistance (Larchmont, N.Y.)

Published: February 21, 2023

A legal assessment of private land conservation in South America.

Journal: Conservation biology : the journal of the Society for Conservation Biology

Published: June 30, 2022

Selecting Data Analytic and Modeling Methods to Support Air Pollution and Environmental Justice Investigations: A Critical Review and Guidance Framework.

Journal: Environmental science & technology

Published: February 08, 2022

Analysis of an IncR Plasmid Carrying blaNDM-1 Linked to an Azithromycin Resistance Region in Enterobacter hormaechei Involved in an Outbreak in Quebec.

Journal: Microbiology spectrum

Published: December 23, 2021

Emergence of Morganellaceae Harboring blaIMP-27 Metalloenzyme in Canada.

Journal: mSphere

Published: May 20, 2021

Absence of transmission of NDM and OXA-48 carbapenemase genes in a chronic care unit of a long-term care facility.

Journal: Journal of infection prevention

Published: August 19, 2020

Carbapenemase-producing Enterobacterales in hospital drains in Southern Ontario, Canada.

Journal: The Journal of hospital infection

Published: July 10, 2020

Household Transmission of Carbapenemase-producing Enterobacterales in Ontario, Canada.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 21, 2020

Arrival of the rare carbapenemase OXA-204 in Canada causing a multispecies outbreak over 3 years.

Journal: The Journal of antimicrobial chemotherapy

Published: March 17, 2020

Enterobacter sp. N18-03635 harbouring blaFRI-6 class A carbapenemase, Canada.

Journal: The Journal of antimicrobial chemotherapy

Published: November 15, 2019

Fosfomycin resistance mediated by fos genes remains rare among extended-spectrum beta-lactamase-producing Escherichia coli clinical isolates recovered from the urine of patients evaluated at Canadian hospitals (CANWARD, 2007-2017).

Journal: Diagnostic microbiology and infectious disease

Published: September 06, 2019